Oklahoma Pharmacies to Receive Over $2.1 Million from CVS Settlement

Oklahoma Pharmacies to Receive Over $2.1 Million from CVS Settlement

More than $2.1 million from a settlement with CVS Caremark will be distributed to hundreds of pharmacies in Oklahoma, state officials announced. Oklahoma Attorney General Gentner Drummond and Insurance Commissioner Glen Mulready confirmed that over 900 eligible pharmacies will receive funds following a prolonged dispute over fees that CVS Caremark allegedly charged improperly for processing prescription claims.

“Pharmacies are essential to the health and well-being of Oklahoma communities, particularly in rural areas,” Drummond stated. “My office is committed to getting these funds to the pharmacies that were improperly charged, and we will continue holding PBMs accountable when they violate Oklahoma law.”

Distribution Process

This payout does not extend to CVS customers. Instead, eligible pharmacies will be contacted directly by the Attorney General’s Office, using information provided by the Oklahoma State Board of Pharmacy. The office will assist these pharmacies in completing the necessary paperwork to receive their payments. The funds stem from fines secured through a settlement initially reached between the Oklahoma Insurance Department and CVS Caremark in 2022.

Significance of the Settlement

This dispute highlights the increasingly scrutinized role of pharmacy benefit managers (PBMs) in determining pharmacy payments for prescription drugs. CVS Caremark operates as a PBM, managing pharmacy benefits and payments for health plans. Oklahoma accused the company of improperly charging transaction fees from September 2020 to October 2021. This is the third settlement with CVS Caremark, with combined recoveries totaling over $7 million for Oklahoma pharmacies.

Details of the CVS Settlement

In January 2022, the Oklahoma Insurance Department reached a settlement with CVS Caremark, alleging improper assessment of transaction fees against pharmacies in violation of state law. CVS Caremark did not admit liability as part of the agreement. Michael Ryan, a finance expert, explained the issue further: “What concerns me more is what happens behind the pharmacy counter. A customer pays their usual copay and walks out with their medication. Everything seems fine. But the pharmacy has its own costs, including what it pays for the drug and what the insurance middleman takes out.”

Those costs add up. And for a small independent pharmacy, there’s only so much room to absorb them.

Eligibility for Settlement Payment

More than 900 pharmacies in Oklahoma are eligible for distribution. Individual CVS customers cannot submit claims. The Oklahoma Attorney General’s Office will oversee the distribution process and contact each affected pharmacy using data from the Oklahoma State Board of Pharmacy to assist in the required paperwork.

Alex Beene, a financial literacy instructor, commented on the nature of the settlement: “Unlike most settlements that go directly to customers and rely on those affected applying for their financial portion, this settlement is more for pharmacies in Oklahoma than those who buy from them.”

Further Settlements

This marks the third settlement involving CVS Caremark, with collective amounts exceeding $7 million returned to Oklahoma pharmacies. Another agreement announced in December 2025 involved over $5 million and dealt with allegations of underpaid pharmacies for drug dispensing. Ryan noted, “Customers may never see these charges on a receipt. What they will notice is when their neighborhood pharmacy stops accepting their insurance, or closes altogether.”

Next Steps

The Oklahoma Attorney General’s Office is tasked with distributing more than $2.1 million to the affected pharmacies. Although this financial assistance helps recover some funds, it does not guarantee pharmacies’ ability to continue future insurance contract prescriptions. Ryan observed: A settlement check can help recover some of that money. But it doesn’t guarantee the pharmacy can afford to keep filling prescriptions under its future insurance contracts.

Leave a Reply

Your email address will not be published. Required fields are marked *